ロード中...
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides
Radioimmunotherapy of non-Hodgkin lymphoma consists of a (90)Y- or (131)I-labeled murine anti-CD20 IgG, but both agents also include a substantial dose of unlabeled anti-CD20 IgG given immediately before the radioconjugate to reduce its uptake in the spleen (primary normal B-cell antigen sink); this...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2820147/ https://ncbi.nlm.nih.gov/pubmed/20127947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24802 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|